Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can treating Mom's ADHD help her Child's symptoms?

NCT ID NCT04240756

Symptom relief Sponsor: University of Maryland, College Park Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 16, 2026 · Last updated Sep 17, 2026 · Updated 1 time

Summary

Researchers are testing whether giving mothers with ADHD a stimulant medication along with behavioral parent training works better than parent training alone for reducing ADHD-related problems in their young children. The study enrolls mothers aged 21 and older who meet criteria for ADHD and their children aged 3 to 8 who show elevated ADHD symptoms. All treatment sessions happen through telehealth, and the team also looks at how to bring this approach into primary care practices.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Extended release mixed amphetamine salts (a stimulant medication) plus behavioral parent training
What this could lead to
If the combined approach works, it could offer families a practical way to get ADHD care for both parent and child through telehealth, without repeated clinic visits.
What could go wrong
This is a behavioral and medication study, not a cure. Stimulant medications can have side effects, and parent training takes time and commitment. Results may not apply to all families or all primary care settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

269 people

The number who actually took part.

Started

Aug 2020

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

3 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Child Inclusion Criteria: * Be at least 3 years old and no more than 8 years old * ADHD medication naive or have not had an adequate trial of stimulant medications * Have ≥5 inactivity or ≥5 hyperactivity symptoms rated as 1 or 2 on the Vanderbilt * Have a CGI-S-ADHD rating ≥4 and \<7 Child Exclusion Criteria: * Severe ADHD (CGI-S-ADHD score of greater than 6) Parent Inclusion Criteria: * Be at least 21 years old and English-speaking * Meet full DSM-5 criteria for ADHD (any subtype) * Have findings on physical examination, laboratory studies, vital signs, and electrocardiogram judged to be normal for age with no contraindications for stimulant medication * Have pulse and blood pressure (BP) within 95% of age and gender mean * Women of childbearing potential agree to use a medically accepted contraception method consistently * Parents with common comorbid conditions will be included provided that: (a) they do not report active suicidal ideation with intent (i.e. Beck Depression Inventory (BDI)-II score of 2 or 3 to Q9 which assesses suicidal thoughts); and (b) if receiving an antidepressant medication, their medication is well-tolerated, has not changed within 30 days, and the prescribing physician approves of their participation in the study * Must have regular access to a computer or phone that can be used to deliver the behavioral parent training Parent Exclusion Criteria: * History of allergic or other severe negative reactions to study medications * Substance abuse in the past 3 months, or a positive baseline urinary toxic screen that is not explained by a time-limited medical circumstance * Current bipolar disorder, schizophrenia, psychoses, or other primary psychiatric disorder requiring other immediate treatment * History of chronic/acute medical disorder for which stimulant therapy would be contraindicated (e.g., glaucoma, hypertension) * Stimulant medication for ADHD in the past 30 days * Is pregnant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADHD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADHD Parenting

Contacts and locations

Locations

  • University of Maryland

    College Park, Maryland, 20742, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.